Craniofacial venous malformations handled by percutaneous sclerotherapy utilizing polidocanol: a single-center expertise.
Acta Radiol. 2018 Aug 15;:284185118795326
Authors: Grieb D, Meila D, Greling B, Jacobs C, Hechtner M, Schlunz-Hendann M, Brassel F
Background Percutaneous remedy with varied sclerosants is a longtime therapy of venous malformations generally. We investigated the protection and effectiveness of polidocanol within the craniofacial area. Goal To current and consider our subjective and goal mid- and long-term outcomes of sufferers with craniofacial venous malformations (CFVM) after percutaneous sclerotherapy utilizing polidocanol. Materials and Strategies Twenty sufferers with CFVM handled by percutaneous sclerotherapy have been adopted up and requested to fill in a questionnaire evaluating ranges of the next CFVM-related signs earlier than and after therapy: ache; purposeful impairment; beauty deformities; and impairment in every day life. Moreover, each measurement discount in addition to procedural-related complication charges have been analyzed. Outcomes Analysis of the questionnaire revealed an enchancment or full aid of CFVM-related signs with important diminished impairment in every day life after percutaneous sclerotherapy. Eighteen (90%) sufferers observed a post-sclerotherapy enchancment of at the very least one in every of their corresponding signs and expressed satisfaction with regard to their therapy. For 13 sufferers, a?>?50% measurement discount of the CFVM may very well be noticed, whereas seven exhibited a?<?50% measurement discount. One minor complication was encountered in 56 therapy periods (1.eight%). Conclusion Percutaneous sclerotherapy utilizing polidocanol is a well-tolerated therapy for CFVM with a low complication price. Dimension discount and constructive outcomes with enchancment of various medical signs will be achieved.
PMID: 30111191 [PubMed – as supplied by publisher]